Learning to segment anatomy and lesions from disparately labeled sources in brain MRI
Meva Himmetoglu, Ilja Ciernik, Ender Konukoglu
TL;DR
This work tackles the challenge of segmenting both healthy brain structures and lesions in MRI when jointly labeled data are scarce. It introduces a dual-path architecture with tissue-focused and lesion-focused encoders, an attention-based fusion head, and an inference-time adaptation guided by meta-learning to maintain healthy-tissue predictions despite lesion disruptions. Training proceeds in three phases—pretraining on task-specific data, meta co-training with synthetic pseudo-lesions, and joint training with real lesion data—enabling joint segmentation from disparately labeled datasets. The method achieves improved joint segmentation performance on BraTS glioblastoma data and demonstrates robustness to domain shifts in an in-house dataset, highlighting its potential for clinically useful brain MRI analysis and treatment monitoring.
Abstract
Segmenting healthy tissue structures alongside lesions in brain Magnetic Resonance Images (MRI) remains a challenge for today's algorithms due to lesion-caused disruption of the anatomy and lack of jointly labeled training datasets, where both healthy tissues and lesions are labeled on the same images. In this paper, we propose a method that is robust to lesion-caused disruptions and can be trained from disparately labeled training sets, i.e., without requiring jointly labeled samples, to automatically segment both. In contrast to prior work, we decouple healthy tissue and lesion segmentation in two paths to leverage multi-sequence acquisitions and merge information with an attention mechanism. During inference, an image-specific adaptation reduces adverse influences of lesion regions on healthy tissue predictions. During training, the adaptation is taken into account through meta-learning and co-training is used to learn from disparately labeled training images. Our model shows an improved performance on several anatomical structures and lesions on a publicly available brain glioblastoma dataset compared to the state-of-the-art segmentation methods.
